Uromodulin Levels and Kidney Disease Risk in Heart Patients
Author Information
Author(s): Michael G Shlipak, Yongmei Li, Caroline Fox, Josef Coresh, Carl Grunfeld, Mary Whooley
Primary Institution: San Francisco VA Medical Center
Hypothesis
Can uromodulin concentrations distinguish CKD risk among individuals with coronary artery disease?
Conclusion
The study found no association between urine uromodulin concentrations and incident CKD in patients with established coronary artery disease.
Supporting Evidence
- The study involved 879 participants with coronary artery disease.
- Uromodulin levels were similar between CKD cases and controls.
- The T/T genotype had lower uromodulin levels compared to the G/G genotype.
Takeaway
This study looked at whether a protein called uromodulin could help predict kidney disease in heart patients, but it didn't find a link.
Methodology
The study genotyped the UMOD SNP in 879 individuals and measured uromodulin levels in a subset of 120 participants, comparing incident CKD cases and controls.
Potential Biases
There may be biases due to the observational nature of the study and the specific population studied.
Limitations
The study had a limited sample size for homozygotes of the minor allele and potential measurement errors in urine collections.
Participant Demographics
Participants were primarily individuals with established coronary artery disease, including a mix of Whites and non-Whites.
Statistical Information
P-Value
0.20
Confidence Interval
0.71-1.26
Statistical Significance
p = 0.88
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website